Alpha, beta Synuclein (AA 119-140) antibody
-
- Target
- Alpha, beta Synuclein
-
Binding Specificity
- AA 119-140
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- Un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF), Flow Cytometry (FACS)
- Purification
- The antibody was purified from mouse ascitic fluids by protein-G affinity chromatography
- Immunogen
- Recombinant human a-synuclein (119-140aa) purified from E. coli
- Clone
- 3B6
- Isotype
- IgG1 kappa
-
-
- Application Notes
- Recommended dilution 1:1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- In Phosphate-Buffered Saline (pH7.4) with 0.1% Sodium Azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C,-80 °C
- Storage Comment
- Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
-
- Target
- Alpha, beta Synuclein
- Alternative Name
- Synuclein-alpha/beta
- Background
- Alpha-synuclein (amino acids 119-140), an acidic neuronal protein of 140 amino acids, is extremely heat-resistant and is natively unfolded with an extended structure primarily composed of random coils. alpha-synuclein has been suggested to be implicated in the pathogenesis of Parkinson's disease and related neurodegenerative disorders, and more recently, to be an important regulatory component of vesicular transport in neuronal cells. Specially, the non-Abeta component of amyloid plaques is a highly amyloidogenic peptide consisting of 35 amino acids which was first identified associated with senile plaques in the Alzheimer's disease brain.
- NCBI Accession
- NP_000336, NP_003076
-